-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637.O2.6 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Treatments and Outcome Predictions in High Risk MDS

Symposia: Myelodysplastic Syndromes – Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Moderators:
Maximilian Stahl, MD, Dana Farber Institute and Eduard Schulz, MD, PhD, National Institutes of Health, National Cancer Institute, Center for Cancer Research
Disclosures:
Stahl: Dedham group: Consultancy; GSK: Membership on an entity's Board of Directors or advisory committees; Rigel: Membership on an entity's Board of Directors or advisory committees; Clinical care options: Other: GME activity ; Novartis: Membership on an entity's Board of Directors or advisory committees, Other: GME activity ; Kymera: Membership on an entity's Board of Directors or advisory committees; Boston Consulting: Consultancy; Sierra Oncology: Membership on an entity's Board of Directors or advisory committees; Curis Oncology: Other: GME activity ; Haymarket Media: Other: GME activity . Schulz: Amgen: Honoraria.
4:00 PM

Jacqueline S. Garcia, MD1, Uwe Platzbecker, MD2, Olatoyosi Odenike3, Shaun Fleming4*, Chun Yew Fong5*, Rachel J. Cook, MD6, Meagan Jacoby7*, Daniel Nowak8*, Brenda Chyla9, Ying Zhou9*, Grace Ku10*, Jalaja Potluri9 and Guillermo Garcia-Manero, MD11

1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
2Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
3The University of Chicago Medicine and Comprehensive Cancer Center, Chicago, IL
4Alfred Health, Melbourne, Australia
5Department of Hematology, Austin Health, Heidelberg, VIC, Australia
6Oregon Health and Science University, Portland, OR
7Washington University-School of Medicine, St. Louis, MO
8Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
9AbbVie Inc, North Chicago, IL
10Genentech Inc., South San Francisco, CA
11University of Texas MD Anderson Cancer Center, Houston, TX

4:15 PM

Wei Yang1*, Sujun Gao2*, Xiaojing Yan3*, Rong Guo4*, Lijie Han4*, Fei Li5*, Yafei Wang6*, Junmin Li7*, Chunkang Chang, MD8*, Haiping Yang9*, Ronghua Hu10*, Hongyan Tong11*, Xingli Zhao12*, Qiubai Li13*, Jingdong Zhang14*, Xin Du, MD15*, Sanfang Tu16*, Cheng Zhang17*, Congmeng Lin18*, Xin Du19*, Zhenling Li20*, Ligen Liu21*, Zhenyu Li22*, Zheng Dong23*, Yixuan Yang24*, Qiying Lu24*, Wenzhi Tian24* and Zhijian Xiao25*

1Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
2The First Hospital of Jilin University, Changchun, China
3The First Hospital of China Medical University, Shenyang, China
4The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
5The First Affiliated Hospital of Nanchang University, Nanchang, China
6Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
8Shanghai Sixth People's Hospital, Shanghai, China
9The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
10Xuanwu Hospital of Capital Medical University, Beijing, China
11First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
12Tianjin People's Hospital, Tianjin, China
13Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
14Ganzhou People's Hospital, Ganzhou, China
15Division of Hematology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
16Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
17Xinqiao Hospital, Army Medical University, Chongqing, China
18Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China
19Guangdong Provincial People's Hospital, Guangzhou, China
20China-Japan Friendship Hospital, Beijing, China
21Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
22Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
23ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Beijing, China
24ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China
25Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

4:30 PM

Douglas Tremblay, MD1, Clifford M Csizmar, MD, PhD2, Courtney D. DiNardo, MD, MSc3, Somedeb Ball, MD4, Noa Rippel, MD1, Danielle E. Hammond, MD3, Tapan M. Kadia, MD3, Farhad Ravandi, MD, MBBS3, Kelly S. Chien, MD3, Grace Van Hyfte5*, Antoine Saliba, MD6, Abhishek A Mangaonkar, MBBS6, Terra L. Lasho, PhD2, Aref Al-Kali, MD6, Marina Kremyanskaya, MD, PhD1, Jonathan Feld, MD1, Lewis R Silverman, MD1, Rami S. Komrokji, MD7, John Mascarenhas, MD1*, Eric Padron, MD7, Guillermo Garcia-Manero, MD8, David A Sallman, MD9, Mrinal M. Patnaik, MD, MBBS2 and Guillermo Montalban-Bravo, MD3

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Vanderbilt University Medical Center, Nashville, TN
5Icahn School of Medicine At Mount Sinai, New York, NY
6Division of Hematology, Mayo Clinic, Rochester, MN
7Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
8University of Texas MD Anderson Cancer Center, Houston, TX
9H. Lee Moffitt Cancer Center, Tampa, FL

4:45 PM

Daniel Nguyen, MD, PhD1, Farhad Ravandi, MD, MBBS2, Sa A. Wang3, Jeffrey L. Jorgensen, MD3, Wei Wang3*, Kelly S. Chien, MD2, Guillermo Montalban-Bravo, MD2, Ghayas C. Issa4, Abhishek Maiti, MD2, Yesid Alvarado Valero, MD2, Naval Daver, MD2, Courtney D. DiNardo, MD, MSc2, Elias Jabbour2, Tapan M. Kadia, MD2, Naveen Pemmaraju, MD2, Musa Yilmaz, MD2*, Jaehyun Lee4*, Pavan Bachireddy, MD4, Uday R. Popat, MD5, Guillermo Garcia-Manero, MD2, Hagop M. Kantarjian, MD2 and Nicholas J. Short, MD2

1University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

5:00 PM

Lok Lam Ngai, MD1,2*, Coen R. Veenstra, MD1,3*, Patrycja Gradowska, PhD4,5*, Angèle Kelder1,2*, Willemijn Scholten1,2*, Alexander N. Snel1,2*, Jesse M. Tettero, MD1,2*, Costa Bachas, PhD1,2*, Dimitri Breems, MD, PhD6, Thomas Fischer7, Bjorn T. Gjertsen, MD, PhD8, Laimonas Griškevičius, MD, PhD9*, Gunnar Juliusson, MD, PhD10, Johan Maertens, MD, PhD11*, Markus G. Manz, MD12,13, Thomas Pabst, MD13,14, Jakob Passweg Sr.13,15*, Kimmo Porkka, MD, PhD16, Canan Alhan, MD1,3*, Theresia M. Westers1,3*, Peter J. M. Valk, PhD17, David C. de Leeuw, MD, PhD1,2*, Bob Lowenberg, MD, PhD5, Gert Ossenkoppele, MD, PhD1,2, Jacqueline Cloos, MD1,2* and Arjan A. van de Loosdrecht, MD, PhD1,3

1Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands
4HOVON Data Center, Rotterdam, Netherlands
5Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
6Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
7Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
8Haukeland University Hospital, Bergen, Norway
9Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
10Lund Stem Cell Center Lund University & Hospital, Lund, Sweden
11Department of Hematology, University Hospitals Leuven, Leuven, Belgium
12Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
13Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
14Institute of Medical Oncology, Berne, Switzerland
15University Hospital | Basel, Basel, Switzerland
16Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
17Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands

5:15 PM

Jan Philipp Bewersdorf, MD1, Tariq Kewan, MBBChir2, Ondrej Blaha, PhD3,4,5*, Maximilian Stahl, MD6, Najla H Al Ali, MS7*, Amy E. DeZern, MD, MHS8, Mikkael A. Sekeres, MD9, Geoffrey L Uy, MD10, Hetty E. Carraway, MD, MBA11, Pinkal Desai, MD, MPH12, Elizabeth A. Griffiths, MD13, Eytan M. Stein14, Andrew M. Brunner, MD15, Christine M. McMahon16, Joshua F. Zeidner, MD17, Michael R. Savona, MD18, Jessica M. Stempel, MD19, Namrata Sonia Chandhok, MD20, Constantine Logothetis, MD21, Gail J. Roboz, MD22, Benjamin Rolles, MD23, Eunice S. Wang, MD13, Amyah C. Harris24*, Maria L Amaya, MD, PhD25, Hayley Hawkins26*, Justin Grenet, MD, MPhil27, Rory M. Shallis, MD28, Zhuoer Xie, MD, MS29, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP30, David A Sallman, MD31, Matteo Giovanni Della Porta, MD32*, Rami S. Komrokji, MD7 and Amer M. Zeidan, MBBS, MHS33

1Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
3School of Public Health, Yale Center for Analytical Sciences, Yale University, New Haven
4Yale Cancer Center, Yale University, New Haven
5School of Public Health, Department of Biostatistics, Yale University, New Haven
6Dana Farber Institute, Boston, MA
7Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
8Sidney Kimmel CCC, Johns Hopkins University, Baltimore, MD
9Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
10Division of Oncology, Washington University School of Medicine, Saint Louis, MO
11Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
12Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY
13Roswell Park Comprehensive Cancer Center, Buffalo, NY
14Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
15Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
16University of Colorado School of Medicine, Aurora, CO
17University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
18Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
19Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
20Division of Hematology, University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center, Miami, FL
21Washington University, Saint Louis, MO
22Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY
23Brigham and Women's Hospital/Harvard Medical School, Boston, MA
24Dana Farber Cancer Institute, Boston
25Division of Hematology, University of Colorado, Aurora, CO
26Vanderbilt University Medical Center, Nashville
27Weill Cornell, New York
28Section of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT
29H. Lee Moffitt Cancer Institute, Tampa, FL
30Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
31H. Lee Moffitt Cancer Center, Tampa, FL
32Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
33Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT

*signifies non-member of ASH